ENDRA Life Sciences (NDRA) EBIT: 2016-2024
Historic EBIT for ENDRA Life Sciences (NDRA) over the last 9 years, with Dec 2024 value amounting to -$10.8 million.
- ENDRA Life Sciences' EBIT fell 36.25% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.5 million, marking a year-over-year increase of 0.03%. This contributed to the annual value of -$10.8 million for FY2024, which is 2.82% down from last year.
- According to the latest figures from FY2024, ENDRA Life Sciences' EBIT is -$10.8 million, which was down 2.82% from -$10.5 million recorded in FY2023.
- Over the past 5 years, ENDRA Life Sciences' EBIT peaked at -$10.5 million during FY2023, and registered a low of -$13.2 million during FY2022.
- In the last 3 years, ENDRA Life Sciences' EBIT had a median value of -$10.8 million in 2024 and averaged -$11.5 million.
- Its EBIT has fluctuated over the past 5 years, first decreased by 14.43% in 2022, then rose by 20.04% in 2023.
- Over the past 5 years, ENDRA Life Sciences' EBIT (Yearly) stood at -$11.5 million in 2020, then rose by 0.03% to -$11.5 million in 2021, then decreased by 14.43% to -$13.2 million in 2022, then rose by 20.04% to -$10.5 million in 2023, then declined by 2.82% to -$10.8 million in 2024.